Premium
Stepwise partitioning of Xp21: a profiling method for XK deletions causative of the McLeod syndrome
Author(s) -
Gassner Christoph,
Brönnimann Chantal,
Merki Yvonne,
MattleGreminger Maja P.,
Sigurdardottir Sonja,
Meyer Eduardo,
Engström Charlotte,
O'Sullivan John D.,
Jung Hans H.,
Frey Beat M.
Publication year - 2017
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/trf.14172
Subject(s) - exon , genetics , breakpoint , biology , gene , polymerase chain reaction , microbiology and biotechnology , chromosomal translocation
BACKGROUND McLeod syndrome (MLS) is hematologically defined by the absence of the red blood cell (RBC) antigen Kx on the transmembrane RBC protein, XK, representing a highly specific diagnostic marker. Direct molecular assessment of XK therefore represents a desirable diagnostic tool. Whereas pathogenic point mutations may be simply identified, partial and complete deletions of XK on Xp21.1, eventually covering adjacent genes and causing multifaceted “continuous gene syndromes,” are difficult to localize. STUDY DESIGN AND METHODS Three different McLeod patient samples were tested using 16 initial positional polymerase chain reaction (PCR) procedures distributed over an approximately 2.8‐Mbp Xp‐chromosomal region, ranging telomeric from MAGEB16 to OTC , centromeric of XK . The molecular breakpoint of one sample with an apparent large Xp deletion was iteratively narrowed down by stepwise positioning further PCR procedures and sequenced. Two mutant XK genes, one previously published and serving as a positive control, were also sequenced. RESULTS We confirmed the positive control as previously published and listed as XK*N.20 by the International Society of Blood Transfusion (ISBT). The other XK showed a novel four‐nucleotide deletion in Exon 1, 195‐198delCCGC (newly listed as XK*N.39 by the ISBT). The third sample had an approximately 151‐kbp X‐chromosomal deletion, reaching from Exon 2 of LANCL3 , across XK to Exon 3 of CYBB (newly listed as XK*N.01.016 by the ISBT). Carrier status of the patients' sister was diagnosed using a diagnostic “gap‐PCR.” CONCLUSIONS The stepwise partitioning of Xp21.1 is pragmatic and cost‐efficient in comparison to other diagnostic techniques such as “massive parallel sequencing” given the rarity of MLS. All males with suspected MLS should be considered for molecular XK profiling.